Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.AWHL · Entity 7871 | Director | December 02, 2025 | December 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date December 02, 2025 · Filed December 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.35 · Expires 2035-12-02 | Direct | 198,097 |
Reported balance
After 2025-12-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-02 · Grant · Acquired 198,097 · Balance 198,097 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2025 Filed Dec 4, 2025 02:29 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | GrantStock Option (Right to Buy) · Derivative | 198,097 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001493152-25-026071 · ownership.xml · derivative · entry 1 Beausang Ellen · CIK 0002061533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,097 Underlying: Common Stock · 198,097 shares Expires 2035-12-02 Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:05 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 4,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-013801 · ownership.xml · derivative · entry 2 Beausang Ellen · CIK 0002061533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,843 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock F3 · derivative.exercise_date: On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:05 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | Exercise / conversionCommon Stock | 4,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-013801 · ownership.xml · nonDerivative · entry 1 Beausang Ellen · CIK 0002061533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 00:59 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 1,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-002229 · ownership.xml · derivative · entry 2 Beausang Ellen · CIK 0002061533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,843 Underlying: Common Stock · 1,615 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock F3 · derivative.exercise_date: On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 00:59 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionCommon Stock | 1,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-002229 · ownership.xml · nonDerivative · entry 1 Beausang Ellen · CIK 0002061533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025. Read SEC document |
| March 11, 2025 Filed Apr 2, 2025 00:57 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantRestricted Stock Units · Derivative | 6,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-002227 · ownership.xml · derivative · entry 1 Beausang Ellen · CIK 0002061533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,458 Underlying: Common Stock · 6,458 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock F2 · derivative.exercise_date: 1,615 RSUs will vest on March 31, 2025 and 4,843 RSUs will vest on date of the annual shareholders' meeting, subject to the Reporting Person's continued service to Aspira Women's Health Inc. through the applicable vesting dates. F2 · derivative.expiration_date: 1,615 RSUs will vest on March 31, 2025 and 4,843 RSUs will vest on date of the annual shareholders' meeting, subject to the Reporting Person's continued service to Aspira Women's Health Inc. through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.